Vaccines to curb F&P Healthcare sales

Vaccines to curb F&P Healthcare sales
Dan Brunskill
Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

More Markets

Vector agrees to sell LPG assets for $150m
Markets

Vector agrees to sell LPG assets for $150m

The deal is subject to regulatory approvals and commercial conditions.

Rebecca Howard 26 Jul 2024
ASX: Australian shares slide to a two-week low as tech drags
Markets

ASX: Australian shares slide to a two-week low as tech drags

Every sector of the Australian share market has lost ground.

AAP 26 Jul 2024
NZ sharemarket down 0.38%
Markets Market close

NZ sharemarket down 0.38%

The S&P/NZX 50 Index closed at the day’s low of 12,349.47, down 46.79 points or 0.38%.

Graham Skellern 26 Jul 2024
The Warehouse’s plight in five charts
Retail Charts

The Warehouse’s plight in five charts

The private equity bid shows the company’s future is still anyone’s guess.

Gregor Thompson 26 Jul 2024